tiprankstipranks
Trending News
More News >

D.Western Therapeutics Faces Tough First Half in 2024

D.Western Therapeutics Faces Tough First Half in 2024

D.Western Therapeutics Institute, Inc. (JP:4576) has released an update.

Don’t Miss TipRanks’ Half-Year Sale

D.Western Therapeutics Institute, Inc. reports a challenging first half of 2024, with net sales slightly up by 19.1% to 223 million yen, yet facing significant losses, including a net loss of 520 million yen attributable to owners. The company’s total assets also decreased to 2,065 million yen compared to the end of the previous year, and no dividends were paid or forecasted for 2024 amidst the downturn. The full-year forecast anticipates a continued decline in performance, with a projected net loss of 1,510 million yen and no improvement in operating or ordinary profits.

For further insights into JP:4576 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1